Drug profile · INN
raloxifene hydrochloride
RALOXIFENE HYDROCHLORIDE
raloxifene hydrochloride (RALOXIFENE HYDROCHLORIDE) is a estrogen receptor beta modulator. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — raloxifene hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
raloxifene hydrochloride (RALOXIFENE HYDROCHLORIDE) is a estrogen receptor beta modulator. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Estrogen receptor beta modulator
Primary target: Estrogen receptor beta
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is raloxifene hydrochloride?
raloxifene hydrochloride (RALOXIFENE HYDROCHLORIDE) is a estrogen receptor beta modulator. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for raloxifene hydrochloride?
RALOXIFENE HYDROCHLORIDE is a marketed brand name for raloxifene hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of raloxifene hydrochloride?
raloxifene hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.